Rezultati pretrage - Helmout Modjtahedi

  • Prikaz rezultata 1 – 8 od 8
Detaljiziraj rezultate
  1. 1
    Therapeutic application of monoclonal antibodies in cancer: advances and challenges

    Therapeutic application of monoclonal antibodies in cancer: advances and challenges od Helmout Modjtahedi, S. Ali, Sharadah Essapen

    Izdano 2012
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  2. 2
    A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer

    A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer od Helmout Modjtahedi, Byoung Chul Cho, Martin C. Michel, Flavio Solca

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  3. 3
    Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines

    Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines od Aryan Stanley, G. Hossein Ashrafi, Alan M. Seddon, Helmout Modjtahedi

    Izdano 2017
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

    Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells od Nikolaos Ioannou, Alan M. Seddon, Angus Dalgleish, David Mackintosh, Helmout Modjtahedi

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression andin vitro invasion

    Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression andin vitro invasion od Pornchai O‐charoenrat, Peter Rhŷs‐Evans, Helmout Modjtahedi, William Court, Gary Box, Suzanne A. Eccles

    Izdano 2000
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells

    Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells od Nikolaos Ioannou, Angus Dalgleish, Alan M. Seddon, David Mackintosh, Ulrich Guertler, Flavio Solca, Helmout Modjtahedi

    Izdano 2011
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research

    Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research od Nauf Bou Antoun, Hiba-Tun-Noor A. Mahmood, Anthony J. Walker, Helmout Modjtahedi, Richard Grose, Athina‐Myrto Chioni

    Izdano 2025
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer

    Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer od Helmout Modjtahedi, Tamas Hickish, Margery Nicolson, J. Moore, JM Styles, S. A. Eccles, Elise Jackson, Janine Salter, John Sloane, M. Loreto Spencer, K. Priest, Isabel Smith Zubiaga, Christopher Dean, M. Gore

    Izdano 1996
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: